May 2023 PMID 37304067

Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches.

Katya Carbone, Fabio Gervasi, Latipa Kozhamzharova, Nazgul Altybaeva, Eda Sönmez Gürer, Javad Sharifi-Rad, Christophe Hano, Daniela Calina

Mentions

3
Peak: 2 in Jan 2024
across 2 sources since May 2023

Extended reach

2,969
potential audience

Total likes

9

Video views

437

Mentions per month

May 2023 – Jan 2024

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Discussions frequently refer to the multi-mechanistic actions of casticin, such as inhibiting enzymes like topoisomerase II, which underscores their interest in its complex bioactivity. Words like 'exciting,' 'promising,' and 'potential' highlight a positive tone and optimistic outlook, though discussions remain exploratory rather than definitive, reflecting both curiosity and cautious anticipation.

AgreementModerate agreement

Most discussions acknowledge the potential of casticin as a promising anticancer candidate, showing general consensus with positive sentiments.

InterestHigh interest

The discussions reflect a high level of curiosity and enthusiasm, with many expressing interest in the multi-mechanistic approaches and recent advancements.

EngagementModerate engagement

Participants actively explore questions about mechanisms and implications, indicating thoughtful engagement, but some may not delve deeply into technical details.

ImpactModerate impact

Few posts suggest the research could significantly influence future therapies, although many recognize its promising potential rather than immediate clinical impact.

Abstract in brief

  • Casticin, a flavonoid extracted from various plants, is known for its anti-inflammatory and antioxidant effects, and recent research highlights its potential as an anticancer agent by targeting multiple cancer-related pathways.
  • Scientific studies since 2018 have expanded understanding of casticin’s mechanisms, showing that it can inhibit enzymes like topoisomerase II and DNA methylase 1, and boost tumor-suppressing microRNA miR-338-3p, which contribute to its anticancer activity.
  • Casticin helps combat cancer by promoting cell death (apoptosis), halting cell division, and preventing metastasis, making it a promising candidate for therapies that target both cancer cells and cancer stem-like cells through epigenetic mechanisms.]

Top posts

Most liked on X and Bluesky
Frontiers - Molecular Biology
@FrontMolBioSci · X

New Research: Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches #MolBioSci https://t.co/dkqvxsWguM

May 26, 2023 · 2,533 followers View post →

All mentions

Frontiers - Molecular Biology
@FrontMolBioSci · X

New Research: Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches #MolBioSci https://t.co/dkqvxsWguM

May 26, 2023 · 2,533 followers View post →